Skip to main content

Animations

MJFF Publications

6811 - 6820 of 8587 Results
Title
Year
  • Year
  • 2019
  • 2020
  • 2020
  • 2020
  • 2020
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer
    Journal Name: Clinical Cancer Research
    Publisher: American Association for Cancer Research (AACR)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1158/1078-0432.ccr-19-1376
    Best OA location URL:
    Citation Count: 243
  • Summary Details
    OPEN
    Title: Activation of the Akt1-CREB pathway promotes RNF146 expression to inhibit PARP1-mediated neuronal death
    Journal Name: Science Signaling
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scisignal.aax7119
    Citation Count: 35
  • Summary Details
    OPEN
    Title: APOE genotype regulates pathology and disease progression in synucleinopathy
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aay3069
    Citation Count: 145
  • Summary Details
    OPEN
    Title: Chronic embedded cortico-thalamic closed-loop deep brain stimulation for the treatment of essential tremor
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aay7680
    Citation Count: 120
  • Summary Details
    OPEN
    Title: Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aax0091
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13181
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Lack of Causal Effects or Genetic Correlation between Restless Legs Syndrome and Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28640
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Factors Associated with Health‐Related Quality of Life in Late‐Stage Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13186
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Fracture Risk Assessment in Atypical Parkinsonian Syndromes
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13146
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Bullous Pemphigoid Associated with Multiple System Atrophy: Case Series
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13160
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.